Site menu
Site menu
Want to invest ethically for a brighter future? (but still make lots of money)?
Take Rask’s FREE Ethical Investing course today.
Take Rask’s FREE online Ethical Investing course.
Polynovo Ltd (ASX:PNV) is an Australian medical device company that designs, develops, and manufactures dermal regeneration solutions using its patented NovoSorb biodegradable polymer technology.
Medical device manufacturer PolyNovo Ltd (ASX: PNV) has had an impressive run recently, with its share price up nearly 30% in just two weeks. Here’s my take.
Australian medical device company PolyNovo Ltd (ASX: PNV) has released its first-half result to the market, but the PolyNovo share price remains effectively unchanged. Here’s my take on PolyNovo’s results.
The Polynovo Ltd (ASX:PNV) share price is up around 7% after announcing European growth.
In just a few weeks, nearly $1 billion has been wiped from the market capitalisation of medical device manufacturer PolyNovo Ltd (ASX:PNV). Are shares cheap today?
The S&P/ASX 200 (INDEXASX:XJO) is expected to open slightly lower on Wednesday. Altium (ASX:ALU) and PolyNovo (ASX:PNV) shares are in the news.
The Polynovo Ltd (ASX:PNV) share price is down 6% in early trading after giving a HY21 update.
Two key sectors that I’ll be researching for growth opportunities in 2021 are healthcare and technology. Here are two I’ll be watching closely next year.
Shares in wound care treatment provider PolyNovo Ltd (ASX: PNV) have gone on a rampage these last few months. Are PolyNovo shares a buy at today’s levels?
With around 2,185 stocks on the ASX, I’ve narrowed it down to three ASX growth shares I’m really liking at the moment.
Medical device manufacturer PolyNovo Ltd (ASX: PNV) has had an impressive run recently, with its share price up nearly 30% in just two weeks. Here’s my take.
Australian medical device company PolyNovo Ltd (ASX: PNV) has released its first-half result to the market, but the PolyNovo share price remains effectively unchanged. Here’s my take on PolyNovo’s results.
The Polynovo Ltd (ASX:PNV) share price is up around 7% after announcing European growth.
In just a few weeks, nearly $1 billion has been wiped from the market capitalisation of medical device manufacturer PolyNovo Ltd (ASX:PNV). Are shares cheap today?
The S&P/ASX 200 (INDEXASX:XJO) is expected to open slightly lower on Wednesday. Altium (ASX:ALU) and PolyNovo (ASX:PNV) shares are in the news.
The Polynovo Ltd (ASX:PNV) share price is down 6% in early trading after giving a HY21 update.
Two key sectors that I’ll be researching for growth opportunities in 2021 are healthcare and technology. Here are two I’ll be watching closely next year.
Shares in wound care treatment provider PolyNovo Ltd (ASX: PNV) have gone on a rampage these last few months. Are PolyNovo shares a buy at today’s levels?
With around 2,185 stocks on the ASX, I’ve narrowed it down to three ASX growth shares I’m really liking at the moment.
The information on this website is general financial advice only. That means, the advice does not take into account your objectives, financial situation or needs. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. Please read our Terms & Conditions and Financial Services Guide before using this website.
© Rask Australia 2020
Rask Media’s Ultimate BNPL Sector Report
Afterpay, Zip, Sezzle… is this the opportunity of a lifetime? Or is BNPL a ticking time bomb? This 7,500-word analyst report takes a deep dive into the BNPL sector and shines a spotlight on each of the major players in this booming market.
Unsubscribe anytime. Read our Terms, Financial Services Guide, Privacy Policy. We’ll never sell your email address. Our company is Australian owned.
As we emerge from COVID-19, some tech companies are growing faster than ever. Rask’s investment analysts have identified 3 growth stocks set to benefit. Big time.
Enter your email below to access this report for free, including the names, ticker codes and analysis.
Unsubscribe anytime. Read our Terms, Financial Services Guide, Privacy Policy. We’ll never sell your email address. Our company is Australian owned.